India · Delayed Price · Currency is INR Glenmark Pharmaceuticals Statistics
Total Valuation
BOM:532296 has a market cap or net worth of INR 649.43 billion. The enterprise value is 643.60 billion.
| Market Cap | 649.43B |
| Enterprise Value | 643.60B |
Important Dates
The next estimated earnings date is Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | Oct 3, 2025 |
Share Statistics
| Current Share Class | 282.20M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 3.12% |
| Owned by Institutions (%) | 37.22% |
| Float | 141.59M |
Valuation Ratios
The trailing PE ratio is 47.69 and the forward PE ratio is 28.31.
| PE Ratio | 47.69 |
| Forward PE | 28.31 |
| PS Ratio | 3.82 |
| PB Ratio | 6.18 |
| P/TBV Ratio | 8.11 |
| P/FCF Ratio | 31.11 |
| P/OCF Ratio | 18.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.08, with an EV/FCF ratio of 30.83.
| EV / Earnings | 47.26 |
| EV / Sales | 3.79 |
| EV / EBITDA | 14.08 |
| EV / EBIT | 16.09 |
| EV / FCF | 30.83 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.77 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.28 |
| Interest Coverage | 19.16 |
Financial Efficiency
Return on equity (ROE) is 14.07% and return on invested capital (ROIC) is 30.42%.
| Return on Equity (ROE) | 14.07% |
| Return on Assets (ROA) | 13.90% |
| Return on Invested Capital (ROIC) | 30.42% |
| Return on Capital Employed (ROCE) | 29.55% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 10.75M |
| Profits Per Employee | 861,931 |
| Employee Count | 15,800 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 1.47 |
Taxes
In the past 12 months, BOM:532296 has paid 6.23 billion in taxes.
| Income Tax | 6.23B |
| Effective Tax Rate | 31.38% |
Stock Price Statistics
The stock price has increased by +25.54% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +25.54% |
| 50-Day Moving Average | 2,258.70 |
| 200-Day Moving Average | 2,076.33 |
| Relative Strength Index (RSI) | 58.09 |
| Average Volume (20 Days) | 16,458 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532296 had revenue of INR 169.83 billion and earned 13.62 billion in profits. Earnings per share was 48.24.
| Revenue | 169.83B |
| Gross Profit | 122.35B |
| Operating Income | 39.99B |
| Pretax Income | 19.85B |
| Net Income | 13.62B |
| EBITDA | 45.72B |
| EBIT | 39.99B |
| Earnings Per Share (EPS) | 48.24 |
Balance Sheet
The company has 11.76 billion in cash and 5.94 billion in debt, with a net cash position of 5.83 billion.
| Cash & Cash Equivalents | 11.76B |
| Total Debt | 5.94B |
| Net Cash | 5.83B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 105.12B |
| Book Value Per Share | 372.48 |
| Working Capital | 49.23B |
Cash Flow
In the last 12 months, operating cash flow was 34.45 billion and capital expenditures -13.58 billion, giving a free cash flow of 20.87 billion.
| Operating Cash Flow | 34.45B |
| Capital Expenditures | -13.58B |
| Depreciation & Amortization | 5.73B |
| Net Borrowing | -23.57B |
| Free Cash Flow | 20.87B |
| FCF Per Share | n/a |
Margins
Gross margin is 72.04%, with operating and profit margins of 23.55% and 8.02%.
| Gross Margin | 72.04% |
| Operating Margin | 23.55% |
| Pretax Margin | 11.69% |
| Profit Margin | 8.02% |
| EBITDA Margin | 26.92% |
| EBIT Margin | 23.55% |
| FCF Margin | 12.29% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.22%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.22% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 10.36% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 0.18% |
| Earnings Yield | 2.10% |
| FCF Yield | 3.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:532296 is 2,497.27, which is 8.51% higher than the current price. The consensus rating is "Buy".
| Price Target | 2,497.27 |
| Price Target Difference | 8.51% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 7.21% |
| EPS Growth Forecast (3Y) | 2.01% |
Stock Splits
The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.
| Last Split Date | Sep 10, 2007 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |